Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, and Large Molecule), By Test Type (ADME, PK, PD, Bioavailability, Bioequivalence) - Global Opportunity Analysis and Industry Forecast, 2019-2026; By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027

Report ID :AMI-496 | Category : Healthcare | Published Date : March, 2020 | Pages : 402 | Format :PDF

Industry Trends

Global bioanalytical testing services market was valued at US$ 1743.80 million in 2018 and is expected to reach US$ 4387.01 million by 2027, growing at an estimated CAGR of 10.9% over the forecast period. Market growth can be attributed to increasing demand for analytical services for large-molecule drugs and biologics, number of biosimilar clinical trials, biopharmaceutical pipeline, approvals for biopharmaceuticals, and number of R&D. On the other hand, during the forecast period pricing pressures faced by major players and regulatory operation, cost and labor are expected to restrain the overall market growth to some extent.

Bioanalytical testing is the method used for the analysis of biotechnological or biological products. Bioanalytical tests are applied in drug discovery, drug development, and drug marketing. In recent years, increased focus on contract research development services by biopharmaceutical companies has created opportunities in the bioanalytical testing services market. Increasing frequency of outsourcing research and development activities by many biopharmaceutical companies to focus on their core competencies is expected to drive the expansion of the global bioanalytical testing services market during the forecast period. In addition, the cost-effectiveness associated with outsourcing services compared to in-house analysis is likely to drive the market even further. The strategy that key players in the pharmaceutical industry are implementing to face market competition is restocking their respective pipelines.

Few factors that are responsible for the growth of bioanalytical testing service are in the specific therapeutic areas of drug development and CRO (Contract Research Organization) that diversify their expertise compared to the pharma companies that also tends to perform clinical trials in broad geographies.

As there has been an increase in complexity as well as the number of standards associated with a single molecule, it may have to comply with the regulatory framework which is accelerating the growth in the outsourcing market of pharmaceutical analytical testing service. For companies to stay ahead in the competition they seek regulatory updates, look up for advisory services and also avail expertise so as to be in synchronization with evolving standards. Moreover, there are harmonized guidelines regularly provided by international organizations like the International Council for Harmonization (ICH), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) amongst others.

There has also been an increase in demand for certain specific types of the test due to combination of molecules, development of biosimilars and other innovative medicines. For the companies it has become mandatory to follow local standards when these companies tries to diversify their business to new location.

The major challenge that is faced by the pharmaceuticals companies is the regulatory operations, cost and labor pressures. In order to procure new products and its approval and maintaining its compliance, manufacturers are struggling a lot, also while assuring the competitive cost of operation. The overall cost of operation has been increased due to high investments in regulatory information systems and labor, because of which pharmaceutical companies have decided to opt for outsourcing which is sustainable for research and development activities.

Demand for bioanalytical testing service is directly proportional to the innovation or new molecule development. Due to competitive pressure, lead-time to market and pricing concerns, the companies have outsourced bioanalytical testing service. The focus has moved to the rapid development of new molecules as the growing development is on customized care as well as on technological advancement have lowered the molecule lifecycle.

The demand from end users has influenced the performance of the market players in the pharmaceutical analytical testing domain. Consumers these days are more anxious about personal care, leading to higher consumption of pharmaceutical products, this is due to the increasing awareness level, improving accessibility, intense marketing efforts and government initiatives. Such consumption showing a rising trend is projected to drive the bioanalytical testing services market over the forecast period.

By Molecule Type Insights

Based on the molecule type the bioanalytical testing service market is divided into small molecule and large molecule. The small molecule segment is subjected to have a lucrative market over the next eight years. Most of the branded and generic drug compounds belong to small molecule category. With patent expiration, most of the generic manufacturers are required to conduct and submit the results of bioanalytical testing. Because of this factor, the segment is subjected to growth in the coming years and is in turn anticipated to aid the global bioanalytical testing services market.

The large molecule segment is anticipated to have healthy growth over the forecasted period. Large molecules are also referred to as biologics. They have therapeutic effects and are based on proteins. The large molecules are as heavy as 150kDa and are made up of several thousands of amino acids. Throughout the development process, the bioanalytical testing of large molecule drugs is needed. The sale of biologics has increased over the years exponentially and the pipeline for biologics is also rich.

Large molecule over the forecast year is expected to exhibit healthy growth. Advanced analytical instruments are needed for testing these molecules as well as to address the technical know-how. There is ample availability of testing infrastructure from bioanalytical service providers. Such a factor has aided the bioanalytical testing services market growth in recent past and is expected to continue the same trend over the forecast period

By Test Type Insights

Based on the test type, the market is further bifurcated into five types such as Absorption Distribution Metabolism Excretion (ADME), Bioavailability, Bioequivalence, Pharmacokinetics (PK) and Pharmacodynamics (PD).

Preclinical studies have made a progressive drug development from Pharmacokinetics (PK) and Pharmacodynamics (PD) analysis that exhibit rapid growth factors and are efficient in nature. As there has been a gradual evolution of drug development into sound pharmacology which has prompted several companies to broaden their service portfolio and to maintain their competitive edge in the market. This can be made evident from the presence of a large number of companies that have a broad service portfolio to serve various pharmaceutical development phases.

The category studies of bioavalilability and bioequivalence is attributed by small molecules of bioanalytical test services which has held a lucrative share in the forecasted period. This category has also attributed branded drug compounds and generic medicines which are largely adopted. Such factors are expected to assist the global biopharmaceutical analytical testing services market

The global bioanalytical testing services market in the year 2018 was stimulated by Bioavailability and Bioequivalence demand for complex, high-end pharmaceutical products and high reliability.

Regional Insights

There has been increasing investment from many developed countries with a further combination of several changes to the standard of clinical trial assessment.

North America was propelled to grow at a higher pace, this is because of the fact that the Original Equipment Manufacturers (OEMs) moved quickly towards electronics manufacturing service providers, as the volume of electronic components in the current pharmaceutical companies had increased effectively. Another reason for North America's market growth is the rapid increase in pharmaceutical manufacturers so as to meet the increasing demand for efficient healthcare. The government here has increased its support to reduce the healthcare cost, thereby the regional pharmaceutical outsourcing market is expected to grow further.

Amongst, major United States based drug manufacturers, a number of strategic alliances have been observed that offer PK investigation service in the region. North America held the largest share in 2018 and is anticipated to retain its dominancy over the future years. This is due to the presence of an effective regulatory structure pertaining to drug development processes of Pharmacokinetics (PK) and Pharmacodynamics (PD).

The market for Asia Pacific is expected to witness lucrative growth, due to the rising demand for outsourcing services which is in comparatively undeveloped markets. China, India, and Manila have been the delivery centres of outsourcing services in this region. For onshore clients and nearshore clients based out of Japan, China has been gaining popularity as a testing delivery location. Such a factor is expected to aid the global bioanalytical testing services market over the forecast period.

Biotechnology Testing Services Market Revenue & Forecast, (US$ Million), 2015 – 2027

Competitive Landscape

The report provides both, qualitative and quantitative research of bioanalytical testing services market, as well as provides comprehensive insights and development methods adopted by the key contenders. The key players present in the market are making collaborations and product launch strategies. The companies are also focusing on expanding their presence in the emerging markets. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

The global bioanalytical testing services market includes some of the major players such as Charles River Laboratories International Inc. (U.S.), BioReliance Corporation (U.S.), WuXi PharmaTech (Cayman) Inc. (China), Bioclin Research Laboratories (Ireland), Eurofins Scientific SE (Luxembourg), SGS (Switzerland), LabCorp (U.S.), PPD Inc. (U.S.), Intertek Group Plc. (U.K.) and PRA Health Sciences (U.S.).

Click on image to enlarge

Bioanalytical testing services Market:

By Molecule type
- Small Molecule
- Large Molecule
By Test type
- ADME
- PK
- PD
- Bioavailability
- Bioequivalence
By Geography
- North America
  - US
  - Canada
  - Mexico
  - Rest of North America
- Europe
  - France
  - The UK
  - Spain
  - Germany
  - Italy
  - Nordic Countries
    - Denmark
    - Finland
    - Iceland
    - Sweden
    - Norway
  - Benelux Union
    - Belgium
    - The Netherlands
    - Luxembourg
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - New Zealand
  - Australia
  - South Korea
  - Southeast Asia
    - Indonesia
    - Thailand
    - Malaysia
    - Singapore
    - Rest of Southeast Asia
  - Rest of Asia Pacific
- Middle East and Africa
  - Saudi Arabia
  - UAE
  - Egypt
  - Kuwait
  - South Africa
  - Rest of Middle East & Africa
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Bioanalytical testing services Market

6. Market Synopsis: Bioanalytical testing services Market

7. Bioanalytical testing services Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Bioanalytical testing services Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Bioanalytical testing services Market

7.6. Porter’s Five Force Analysis

8. Global Bioanalytical testing services Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global Bioanalytical testing services Market Revenue (US$ Mn)

8.2. Global Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

8.2.1. Small Molecule

8.2.1.1. Definition

8.2.1.2. Market Estimation and Penetration, 2015 – 2018

8.2.1.3. Market Forecast, 2019 – 2027

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2015 – 2018

8.2.1.5.1.2. Market Forecast, 2019 – 2027

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2015 – 2018

8.2.1.5.2.2. Market Forecast, 2019 – 2027

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 – 2018

8.2.1.5.3.2. Market Forecast, 2019 – 2027

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 – 2018

8.2.1.5.4.2. Market Forecast, 2019 – 2027

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2015 – 2018

8.2.1.5.5.2. Market Forecast, 2019 – 2027

8.2.2. Large Molecule

8.2.2.1. Definition

8.2.2.2. Market Estimation and Penetration, 2015 – 2018

8.2.2.3. Market Forecast, 2019 – 2027

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2015 – 2018

8.2.2.5.1.2. Market Forecast, 2019 – 2027

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2015 – 2018

8.2.2.5.2.2. Market Forecast, 2019 – 2027

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 – 2018

8.2.2.5.3.2. Market Forecast, 2019 – 2027

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 – 2018

8.2.2.5.4.2. Market Forecast, 2019 – 2027

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2015 – 2018

8.2.2.5.5.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Molecule type

9. Global Bioanalytical testing services Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

9.2.1. ADME

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2015 – 2018

9.2.1.3. Market Forecast, 2019 – 2027

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2015 – 2018

9.2.1.5.1.2. Market Forecast, 2019 – 2027

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2015 – 2018

9.2.1.5.2.2. Market Forecast, 2019 – 2027

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 – 2018

9.2.1.5.3.2. Market Forecast, 2019 – 2027

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 – 2018

9.2.1.5.4.2. Market Forecast, 2019 – 2027

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2015 – 2018

9.2.1.5.5.2. Market Forecast, 2019 – 2027

9.2.2. PK

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2015 – 2018

9.2.2.3. Market Forecast, 2019 – 2027

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2015 – 2018

9.2.2.5.1.2. Market Forecast, 2019 – 2027

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2015 – 2018

9.2.2.5.2.2. Market Forecast, 2019 – 2027

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 – 2018

9.2.2.5.3.2. Market Forecast, 2019 – 2027

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 – 2018

9.2.2.5.4.2. Market Forecast, 2019 – 2027

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2015 – 2018

9.2.2.5.5.2. Market Forecast, 2019 – 2027

9.2.3. PD

9.2.3.1. Definition

9.2.3.2. Market Estimation and Penetration, 2015 – 2018

9.2.3.3. Market Forecast, 2019 – 2027

9.2.3.4. Compound Annual Growth Rate (CAGR)

9.2.3.5. Regional Bifurcation

9.2.3.5.1. North America

9.2.3.5.1.1. Market Estimation, 2015 – 2018

9.2.3.5.1.2. Market Forecast, 2019 – 2027

9.2.3.5.2. Europe

9.2.3.5.2.1. Market Estimation, 2015 – 2018

9.2.3.5.2.2. Market Forecast, 2019 – 2027

9.2.3.5.3. Asia Pacific

9.2.3.5.3.1. Market Estimation, 2015 – 2018

9.2.3.5.3.2. Market Forecast, 2019 – 2027

9.2.3.5.4. Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2015 – 2018

9.2.3.5.4.2. Market Forecast, 2019 – 2027

9.2.3.5.5. Latin America

9.2.3.5.5.1. Market Estimation, 2015 – 2018

9.2.3.5.5.2. Market Forecast, 2019 – 2027

9.2.4. Bioavailability

9.2.4.1. Definition

9.2.4.2. Market Estimation and Penetration, 2015 – 2018

9.2.4.3. Market Forecast, 2019 – 2027

9.2.4.4. Compound Annual Growth Rate (CAGR)

9.2.4.5. Regional Bifurcation

9.2.4.5.1. North America

9.2.4.5.1.1. Market Estimation, 2015 – 2018

9.2.4.5.1.2. Market Forecast, 2019 – 2027

9.2.4.5.2. Europe

9.2.4.5.2.1. Market Estimation, 2015 – 2018

9.2.4.5.2.2. Market Forecast, 2019 – 2027

9.2.4.5.3. Asia Pacific

9.2.4.5.3.1. Market Estimation, 2015 – 2018

9.2.4.5.3.2. Market Forecast, 2019 – 2027

9.2.4.5.4. Middle East and Africa

9.2.4.5.4.1. Market Estimation, 2015 – 2018

9.2.4.5.4.2. Market Forecast, 2019 – 2027

9.2.4.5.5. Latin America

9.2.4.5.5.1. Market Estimation, 2015 – 2018

9.2.4.5.5.2. Market Forecast, 2019 – 2027

9.2.5. Bioequivalence

9.2.5.1. Definition

9.2.5.2. Market Estimation and Penetration, 2015 – 2018

9.2.5.3. Market Forecast, 2019 – 2027

9.2.5.4. Compound Annual Growth Rate (CAGR)

9.2.5.5. Regional Bifurcation

9.2.5.5.1. North America

9.2.5.5.1.1. Market Estimation, 2015 – 2018

9.2.5.5.1.2. Market Forecast, 2019 – 2027

9.2.5.5.2. Europe

9.2.5.5.2.1. Market Estimation, 2015 – 2018

9.2.5.5.2.2. Market Forecast, 2019 – 2027

9.2.5.5.3. Asia Pacific

9.2.5.5.3.1. Market Estimation, 2015 – 2018

9.2.5.5.3.2. Market Forecast, 2019 – 2027

9.2.5.5.4. Middle East and Africa

9.2.5.5.4.1. Market Estimation, 2015 – 2018

9.2.5.5.4.2. Market Forecast, 2019 – 2027

9.2.5.5.5. Latin America

9.2.5.5.5.1. Market Estimation, 2015 – 2018

9.2.5.5.5.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Test type

10. North America Bioanalytical testing services Market Analysis and Forecasts, 2019 - 2027

10.1. Overview

10.1.1. North America Bioanalytical testing services Market Revenue (US$ Mn)

10.2. North America Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

10.2.1. Small Molecule

10.2.2. Large Molecule

10.3. North America Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

10.3.1. ADME

10.3.2. PK

10.3.3. PD

10.3.4. Bioavailability

10.3.5. Bioequivalence

10.4. North America Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Country

10.4.1. U.S

10.4.1.1. U.S Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

10.4.1.1.1. Small Molecule

10.4.1.1.2. Large Molecule

10.4.1.2. U.S Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

10.4.1.2.1. ADME

10.4.1.2.2. PK

10.4.1.2.3. PD

10.4.1.2.4. Bioavailability

10.4.1.2.5. Bioequivalence

10.4.2. Canada

10.4.2.1. Canada Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

10.4.2.1.1. Small Molecule

10.4.2.1.2. Large Molecule

10.4.2.2. Canada Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

10.4.2.2.1. ADME

10.4.2.2.2. PK

10.4.2.2.3. PD

10.4.2.2.4. Bioavailability

10.4.2.2.5. Bioequivalence

10.4.3. Mexico

10.4.3.1. Mexico Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

10.4.3.1.1. Small Molecule

10.4.3.1.2. Large Molecule

10.4.3.2. Mexico Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

10.4.3.2.1. ADME

10.4.3.2.2. PK

10.4.3.2.3. PD

10.4.3.2.4. Bioavailability

10.4.3.2.5. Bioequivalence

10.4.4. Rest of North America

10.4.4.1. Rest of North America Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

10.4.4.1.1. Small Molecule

10.4.4.1.2. Large Molecule

10.4.4.2. Rest of North America Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

10.4.4.2.1. ADME

10.4.4.2.2. PK

10.4.4.2.3. PD

10.4.4.2.4. Bioavailability

10.4.4.2.5. Bioequivalence

10.5. Key Segment for Channeling Investments

10.5.1. By Country

10.5.2. By Molecule type

10.5.3. By Test type

11. Europe Bioanalytical testing services Market Analysis and Forecasts, 2019 - 2027

11.1. Overview

11.1.1. Europe Bioanalytical testing services Market Revenue (US$ Mn)

11.2. Europe Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

11.2.1. Small Molecule

11.2.2. Large Molecule

11.3. Europe Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

11.3.1. ADME

11.3.2. PK

11.3.3. PD

11.3.4. Bioavailability

11.3.5. Bioequivalence

11.4. Europe Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Country

11.4.1. France

11.4.1.1. France Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

11.4.1.1.1. Small Molecule

11.4.1.1.2. Large Molecule

11.4.1.2. France Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

11.4.1.2.1. ADME

11.4.1.2.2. PK

11.4.1.2.3. PD

11.4.1.2.4. Bioavailability

11.4.1.2.5. Bioequivalence

11.4.2. The UK

11.4.2.1. The UK Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

11.4.2.1.1. Small Molecule

11.4.2.1.2. Large Molecule

11.4.2.2. The UK Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

11.4.2.2.1. ADME

11.4.2.2.2. PK

11.4.2.2.3. PD

11.4.2.2.4. Bioavailability

11.4.2.2.5. Bioequivalence

11.4.3. Spain

11.4.3.1. Spain Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

11.4.3.1.1. Small Molecule

11.4.3.1.2. Large Molecule

11.4.3.2. Spain Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

11.4.3.2.1. ADME

11.4.3.2.2. PK

11.4.3.2.3. PD

11.4.3.2.4. Bioavailability

11.4.3.2.5. Bioequivalence

11.4.4. Germany

11.4.4.1. Germany Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

11.4.4.1.1. Small Molecule

11.4.4.1.2. Large Molecule

11.4.4.2. Germany Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

11.4.4.2.1. ADME

11.4.4.2.2. PK

11.4.4.2.3. PD

11.4.4.2.4. Bioavailability

11.4.4.2.5. Bioequivalence

11.4.5. Italy

11.4.5.1. Italy Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

11.4.5.1.1. Small Molecule

11.4.5.1.2. Large Molecule

11.4.5.2. Italy Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

11.4.5.2.1. ADME

11.4.5.2.2. PK

11.4.5.2.3. PD

11.4.5.2.4. Bioavailability

11.4.5.2.5. Bioequivalence

11.4.6. Nordic Countries

11.4.6.1. Nordic Countries Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

11.4.6.1.1. Small Molecule

11.4.6.1.2. Large Molecule

11.4.6.2. Nordic Countries Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

11.4.6.2.1. ADME

11.4.6.2.2. PK

11.4.6.2.3. PD

11.4.6.2.4. Bioavailability

11.4.6.2.5. Bioequivalence

11.4.6.3. Nordic Countries Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Country

11.4.6.3.1. Denmark

11.4.6.3.2. Finland

11.4.6.3.3. Iceland

11.4.6.3.4. Sweden

11.4.6.3.5. Norway

11.4.7. Benelux Union

11.4.7.1. Benelux Union Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

11.4.7.1.1. Small Molecule

11.4.7.1.2. Large Molecule

11.4.7.2. Benelux Union Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

11.4.7.2.1. ADME

11.4.7.2.2. PK

11.4.7.2.3. PD

11.4.7.2.4. Bioavailability

11.4.7.2.5. Bioequivalence

11.4.7.3. Benelux Union Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Country

11.4.7.3.1. Belgium

11.4.7.3.2. The Netherlands

11.4.7.3.3. Luxembourg

11.4.8. Rest of Europe

11.4.8.1. Rest of Europe Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

11.4.8.1.1. Small Molecule

11.4.8.1.2. Large Molecule

11.4.8.2. Rest of Europe Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

11.4.8.2.1. ADME

11.4.8.2.2. PK

11.4.8.2.3. PD

11.4.8.2.4. Bioavailability

11.4.8.2.5. Bioequivalence

11.5. Key Segment for Channeling Investments

11.5.1. By Country

11.5.2. By Molecule type

11.5.3. By Test type

12. Asia Pacific Bioanalytical testing services Market Analysis and Forecasts, 2019 - 2027

12.1. Overview

12.1.1. Asia Pacific Bioanalytical testing services Market Revenue (US$ Mn)

12.2. Asia Pacific Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

12.2.1. Small Molecule

12.2.2. Large Molecule

12.3. Asia Pacific Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

12.3.1. ADME

12.3.2. PK

12.3.3. PD

12.3.4. Bioavailability

12.3.5. Bioequivalence

12.4. Asia Pacific Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Country

12.4.1. China

12.4.1.1. China Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

12.4.1.1.1. Small Molecule

12.4.1.1.2. Large Molecule

12.4.1.2. China Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

12.4.1.2.1. ADME

12.4.1.2.2. PK

12.4.1.2.3. PD

12.4.1.2.4. Bioavailability

12.4.1.2.5. Bioequivalence

12.4.2. Japan

12.4.2.1. Japan Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

12.4.2.1.1. Small Molecule

12.4.2.1.2. Large Molecule

12.4.2.2. Japan Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

12.4.2.2.1. ADME

12.4.2.2.2. PK

12.4.2.2.3. PD

12.4.2.2.4. Bioavailability

12.4.2.2.5. Bioequivalence

12.4.3. India

12.4.3.1. India Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

12.4.3.1.1. Small Molecule

12.4.3.1.2. Large Molecule

12.4.3.2. India Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

12.4.3.2.1. ADME

12.4.3.2.2. PK

12.4.3.2.3. PD

12.4.3.2.4. Bioavailability

12.4.3.2.5. Bioequivalence

12.4.4. New Zealand

12.4.4.1. New Zealand Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

12.4.4.1.1. Small Molecule

12.4.4.1.2. Large Molecule

12.4.4.2. New Zealand Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

12.4.4.2.1. ADME

12.4.4.2.2. PK

12.4.4.2.3. PD

12.4.4.2.4. Bioavailability

12.4.4.2.5. Bioequivalence

12.4.5. Australia

12.4.5.1. Australia Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

12.4.5.1.1. Small Molecule

12.4.5.1.2. Large Molecule

12.4.5.2. Australia Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

12.4.5.2.1. ADME

12.4.5.2.2. PK

12.4.5.2.3. PD

12.4.5.2.4. Bioavailability

12.4.5.2.5. Bioequivalence

12.4.6. South Korea

12.4.6.1. South Korea Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

12.4.6.1.1. Small Molecule

12.4.6.1.2. Large Molecule

12.4.6.2. South Korea Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

12.4.6.2.1. ADME

12.4.6.2.2. PK

12.4.6.2.3. PD

12.4.6.2.4. Bioavailability

12.4.6.2.5. Bioequivalence

12.4.7. Southeast Asia

12.4.7.1. Southeast Asia Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

12.4.7.1.1. Small Molecule

12.4.7.1.2. Large Molecule

12.4.7.2. Southeast Asia Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

12.4.7.2.1. ADME

12.4.7.2.2. PK

12.4.7.2.3. PD

12.4.7.2.4. Bioavailability

12.4.7.2.5. Bioequivalence

12.4.7.3. Southeast Asia Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Country

12.4.7.3.1. Indonesia

12.4.7.3.2. Thailand

12.4.7.3.3. Malaysia

12.4.7.3.4. Singapore

12.4.7.3.5. Rest of Southeast Asia

12.4.8. Rest of Asia Pacific

12.4.8.1. Rest of Asia Pacific Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

12.4.8.1.1. Small Molecule

12.4.8.1.2. Large Molecule

12.4.8.2. Rest of Asia Pacific Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

12.4.8.2.1. ADME

12.4.8.2.2. PK

12.4.8.2.3. PD

12.4.8.2.4. Bioavailability

12.4.8.2.5. Bioequivalence

12.5. Key Segment for Channeling Investments

12.5.1. By Country

12.5.2. By Molecule type

12.5.3. By Test type

13. Middle East and Africa Bioanalytical testing services Market Analysis and Forecasts, 2019 - 2027

13.1. Overview

13.1.1. Middle East and Africa Bioanalytical testing services Market Revenue (US$ Mn)

13.2. Middle East and Africa Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

13.2.1. Small Molecule

13.2.2. Large Molecule

13.3. Middle East and Africa Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

13.3.1. ADME

13.3.2. PK

13.3.3. PD

13.3.4. Bioavailability

13.3.5. Bioequivalence

13.4. Middle East and Africa Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Country

13.4.1. Saudi Arabia

13.4.1.1. Saudi Arabia Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

13.4.1.1.1. Small Molecule

13.4.1.1.2. Large Molecule

13.4.1.2. Saudi Arabia Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

13.4.1.2.1. ADME

13.4.1.2.2. PK

13.4.1.2.3. PD

13.4.1.2.4. Bioavailability

13.4.1.2.5. Bioequivalence

13.4.2. UAE

13.4.2.1. UAE Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

13.4.2.1.1. Small Molecule

13.4.2.1.2. Large Molecule

13.4.2.2. UAE Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

13.4.2.2.1. ADME

13.4.2.2.2. PK

13.4.2.2.3. PD

13.4.2.2.4. Bioavailability

13.4.2.2.5. Bioequivalence

13.4.3. Egypt

13.4.3.1. Egypt Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

13.4.3.1.1. Small Molecule

13.4.3.1.2. Large Molecule

13.4.3.2. Egypt Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

13.4.3.2.1. ADME

13.4.3.2.2. PK

13.4.3.2.3. PD

13.4.3.2.4. Bioavailability

13.4.3.2.5. Bioequivalence

13.4.4. Kuwait

13.4.4.1. Kuwait Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

13.4.4.1.1. Small Molecule

13.4.4.1.2. Large Molecule

13.4.4.2. Kuwait Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

13.4.4.2.1. ADME

13.4.4.2.2. PK

13.4.4.2.3. PD

13.4.4.2.4. Bioavailability

13.4.4.2.5. Bioequivalence

13.4.5. South Africa

13.4.5.1. South Africa Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

13.4.5.1.1. Small Molecule

13.4.5.1.2. Large Molecule

13.4.5.2. South Africa Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

13.4.5.2.1. ADME

13.4.5.2.2. PK

13.4.5.2.3. PD

13.4.5.2.4. Bioavailability

13.4.5.2.5. Bioequivalence

13.4.6. Rest of Middle East & Africa

13.4.6.1. Rest of Middle East & Africa Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

13.4.6.1.1. Small Molecule

13.4.6.1.2. Large Molecule

13.4.6.2. Rest of Middle East & Africa Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

13.4.6.2.1. ADME

13.4.6.2.2. PK

13.4.6.2.3. PD

13.4.6.2.4. Bioavailability

13.4.6.2.5. Bioequivalence

13.5. Key Segment for Channeling Investments

13.5.1. By Country

13.5.2. By Molecule type

13.5.3. By Test type

14. Latin America Bioanalytical testing services Market Analysis and Forecasts, 2019 - 2027

14.1. Overview

14.1.1. Latin America Bioanalytical testing services Market Revenue (US$ Mn)

14.2. Latin America Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

14.2.1. Small Molecule

14.2.2. Large Molecule

14.3. Latin America Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

14.3.1. ADME

14.3.2. PK

14.3.3. PD

14.3.4. Bioavailability

14.3.5. Bioequivalence

14.4. Latin America Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Country

14.4.1. Brazil

14.4.1.1. Brazil Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

14.4.1.1.1. Small Molecule

14.4.1.1.2. Large Molecule

14.4.1.2. Brazil Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

14.4.1.2.1. ADME

14.4.1.2.2. PK

14.4.1.2.3. PD

14.4.1.2.4. Bioavailability

14.4.1.2.5. Bioequivalence

14.4.2. Argentina

14.4.2.1. Argentina Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

14.4.2.1.1. Small Molecule

14.4.2.1.2. Large Molecule

14.4.2.2. Argentina Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

14.4.2.2.1. ADME

14.4.2.2.2. PK

14.4.2.2.3. PD

14.4.2.2.4. Bioavailability

14.4.2.2.5. Bioequivalence

14.4.3. Rest of Latin America

14.4.3.1. Rest of Latin America Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Molecule type

14.4.3.1.1. Small Molecule

14.4.3.1.2. Large Molecule

14.4.3.2. Rest of Latin America Bioanalytical testing services Market Revenue (US$ Mn) and Forecasts, By Test type

14.4.3.2.1. ADME

14.4.3.2.2. PK

14.4.3.2.3. PD

14.4.3.2.4. Bioavailability

14.4.3.2.5. Bioequivalence

14.5. Key Segment for Channeling Investments

14.5.1. By Country

14.5.2. By Molecule type

14.5.3. By Test type

15. Competitive Benchmarking

15.1. Market Share Analysis, 2018

15.2. Global Presence and Growth Strategies

15.2.1. Mergers and Acquisitions

15.2.2. Product Launches

15.2.3. Investments Trends

15.2.4. R&D Initiatives

16. Player Profiles

16.1. Bioclin Research Laboratories

16.1.1. Company Details

16.1.2. Company Overview

16.1.3. Product Offerings

16.1.4. Key Developments

16.1.5. Financial Analysis

16.1.6. SWOT Analysis

16.1.7. Business Strategies

16.2. BioReliance Corporation

16.2.1. Company Details

16.2.2. Company Overview

16.2.3. Product Offerings

16.2.4. Key Developments

16.2.5. Financial Analysis

16.2.6. SWOT Analysis

16.2.7. Business Strategies

16.3. Charles River Laboratories International Inc.

16.3.1. Company Details

16.3.2. Company Overview

16.3.3. Product Offerings

16.3.4. Key Developments

16.3.5. Financial Analysis

16.3.6. SWOT Analysis

16.3.7. Business Strategies

16.4. Eurofins Scientific SE

16.4.1. Company Details

16.4.2. Company Overview

16.4.3. Product Offerings

16.4.4. Key Developments

16.4.5. Financial Analysis

16.4.6. SWOT Analysis

16.4.7. Business Strategies

16.5. Intertek Group Plc.

16.5.1. Company Details

16.5.2. Company Overview

16.5.3. Product Offerings

16.5.4. Key Developments

16.5.5. Financial Analysis

16.5.6. SWOT Analysis

16.5.7. Business Strategies

16.6. LabCorp

16.6.1. Company Details

16.6.2. Company Overview

16.6.3. Product Offerings

16.6.4. Key Developments

16.6.5. Financial Analysis

16.6.6. SWOT Analysis

16.6.7. Business Strategies

16.7. PPD Inc.

16.7.1. Company Details

16.7.2. Company Overview

16.7.3. Product Offerings

16.7.4. Key Developments

16.7.5. Financial Analysis

16.7.6. SWOT Analysis

16.7.7. Business Strategies

16.8. PRA Health Sciences

16.8.1. Company Details

16.8.2. Company Overview

16.8.3. Product Offerings

16.8.4. Key Developments

16.8.5. Financial Analysis

16.8.6. SWOT Analysis

16.8.7. Business Strategies

16.9. SGS

16.9.1. Company Details

16.9.2. Company Overview

16.9.3. Product Offerings

16.9.4. Key Developments

16.9.5. Financial Analysis

16.9.6. SWOT Analysis

16.9.7. Business Strategies

16.10. WuXi PharmaTech (Cayman) Inc.

16.10.1. Company Details

16.10.2. Company Overview

16.10.3. Product Offerings

16.10.4. Key Developments

16.10.5. Financial Analysis

16.10.6. SWOT Analysis

16.10.7. Business Strategies

16.11 Other Market Participants

17. Key Findings

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources: